Home
About
Overview
Sharing Data
ORCID
Help
History (10)
Acetyldigitoxins
Effector CD4 T-cell transition to memory requires late cognate interactions that induce autocrine IL-2.
Factor IXa
"Don't lose hope early": Hemorrhagic diffuse axonal injury on head computed tomography is not associated with poor outcome in moderate to severe traumatic brain injury patients.
Toll-like receptor 9 (TLR9) agonists in the treatment of cancer.
See All 10 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Toll-like receptor 9 (TLR9) agonists in the treatment of cancer.
Krieg AM. Toll-like receptor 9 (TLR9) agonists in the treatment of cancer. Oncogene. 2008 Jan 07; 27(2):161-7.
View in:
PubMed
subject areas
Antineoplastic Agents
Antineoplastic Combined Chemotherapy Protocols
Humans
Models, Biological
Neoplasms
Toll-Like Receptor 9
authors with profiles
Arthur M Krieg MD